Skip to content
← All claims
Health · Cancer medicines · MCCF
The claim

Health Minister Joe Abela said in 2024 that cancer medicines would move from the Malta Community Chest Fund to government administration; this did not happen.

Erol Cutajar · PN candidate · PN
4 May 2026 · PN press conference · 4 May
Also stated by: Ryan Callus · 3 May 2026 · PN mass rally · 3 May
2 politicians on the record with this claim

Documentary fact. November 2024: Health Minister Jo Etienne Abela told parliament that cancer-medicine financing would transfer from the Malta Community Chest Fund (MCCF) to the Health Ministry within 12 months. Twettiq tal-Baġit 2024 and 2025 targeted searches for 'MCCF', 'Malta Community Chest Fund' and 'finanzjament tal-mediċini tal-kanċer' return ZERO results — the commitment is not in the official implementation register. The Shift News (Jan 2026) reported the unkept promise. President Spiteri Debono confirmed late-2024 that MCCF cancer expenses had reached €22M in 2024 alone — MCCF still carrying the financing.

Verdict
True

Documentary fact. November 2024: Health Minister Jo Etienne Abela told parliament that cancer-medicine financing would transfer from the Malta Community Chest Fund (MCCF) to the Health Ministry within 12 months. Twettiq tal-Baġit 2024 and 2025 targeted searches for 'MCCF', 'Malta Community Chest Fund' and 'finanzjament tal-mediċini tal-kanċer' return ZERO results — the commitment is not in the official implementation register. The Shift News (Jan 2026) reported the unkept promise. President Spiteri Debono confirmed late-2024 that MCCF cancer expenses had reached €22M in 2024 alone — MCCF still carrying the financing.

TrueMostly true+contextMixed opinionUnprovenMisleadingUnlikelyFalse
Analysis
Editorial note

We tested Cutajar's claim against the November 2024 parliamentary record of Health Minister Joe Abela's commitment, Twettiq tal-Baġit 2024 and 2025 implementation registers, The Shift News January 2026 follow-up reporting, and President Spiteri Debono's late-2024 MCCF expenses statement. The methodological question is whether the public ministerial commitment to transfer cancer-medicine financing from MCCF to the Health Ministry within 12 months has any visible implementation track-record.

Verdict lands at True because Twettiq 2024 and 2025 searches for 'MCCF' and 'finanzjament tal-mediċini tal-kanċer' return zero implementation entries, The Shift News confirmed the missed deadline in January 2026, and the President's statement that MCCF cancer expenses hit €22M in 2024 alone confirms MCCF was still carrying the financing. The deep-dive lays out the parliamentary commitment, the absent Twettiq entries, and the unavoidable caveat that a quiet operational transfer outside Twettiq tracking would change the picture; this editorial note is methodology only.

HealthCancer medicinesMCCFGovernment promisesTwettiq
Sources
Where this comes from
Maltese Parliament — November 2024 Health Minister statement
Primary source. Joe Abela's parliamentary commitment to transfer cancer-medicine financing from MCCF within 12 months.
parlament.mt ↗
Twettiq tal-Baġit 2024 — implementation register
OPM implementation tracker. Targeted search for MCCF / cancer-medicine transfer returns zero results.
opm.gov.mt ↗
Twettiq tal-Baġit 2025 — implementation register
OPM 2025 report. Same absence of MCCF transfer measure.
opm.gov.mt ↗
The Shift News — January 2026 unkept-promise reporting
Investigative reporting on the missed 12-month deadline and ministerial silence.
theshiftnews.com ↗
President Myriam Spiteri Debono — late-2024 MCCF statement
President's statement that MCCF cancer expenses reached €22M in 2024 alone — confirming MCCF still financing.
president.gov.mt ↗
Malta Community Chest Fund (MCCF)
Charitable foundation under presidential patronage, currently funding cancer-medicine procurement that Abela committed to transfer.
mccf.mt ↗
PN press conference — 4 May 2026
Original Erol Cutajar statement on the unkept cancer-medicines promise.
www.pn.org.mt ↗
Original claim
www.pn.org.mt ↗

Did the 2024 promise to shift cancer medicines from MCCF to government really not happen

The Malta Community Chest Fund (MCCF) is a publicly-supported charitable foundation chaired by the President of Malta, supporting medical and humanitarian causes — most prominently the funding of cancer medicines and treatments not covered by the public health system. It has historically functioned as a critical safety net for patients facing high-cost cancer therapies.

The November 2024 announcement

In November 2024, Health Minister Jo Etienne Abela addressed parliament on the long-running question of whether cancer-medicine financing should be moved from the charitable MCCF to direct government responsibility. Key elements:

  • The Health Ministry would take over responsibility for financing and procurement of cancer medicines from the MCCF.
  • 12-month deadline for completion (i.e., by November 2025).
  • MCCF would continue some cancer-care responsibilities but the funding burden would shift to the state.

The announcement was politically significant: charitable funding of essential medicines had been criticised by multiple medical-profession voices over the years as inappropriate for a state with Malta's GDP and health-system resources.

What's actually happened since

As of mid-2026:

  • The transfer has not been publicly completed.
  • MCCF continues to fund cancer treatments. President Spiteri Debono confirmed in late-2024 that MCCF cancer expenses for 2024 alone had reached €22 million.
  • The 12-month self-imposed deadline (November 2025) was missed.
  • The Shift News (January 2026 article) explicitly flagged the unkept promise: 'the self-imposed deadline was quietly ignored towards the end of last year'.
  • No public announcements from the Health Ministry, President's Office, or Cabinet confirming progress or completion.

On 'absolutely nothing' framing

Cutajar's framing — 'minn dan kollu ma sar assolutament xejn' — is broadly fair on the publicly-visible record. There may be ongoing internal procurement, contracting, or system-design work that hasn't been publicly disclosed. But on the visible deliverable — the actual transfer of cancer-medicine funding from MCCF to government — there is no public confirmation of progress.

What may have constrained the timeline:

  • Procurement complexity for high-cost oncology medicines.
  • Existing MCCF-supplier relationships and contractual continuity.
  • Health Ministry budget capacity given competing priorities.

Even acknowledging these complications, a 12-month deadline that's now 6+ months overdue without public update is what Cutajar's claim describes.

So is the claim accurate?

Yes. The November 2024 promise is on the parliamentary record; the 12-month deadline is on the parliamentary record; the missed deadline is documented in independent press reporting. True.